Task: Answer the multiple choice question.
Question: Which compound exhibits a -46.441% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) COc1cccc(CN(C)CC(=O)Nc2ccccc2C(=O)Nc2ccccc2)c1OC
b.) CCCCN(CC)C(=O)Cn1ncc2c3ccccc3n(CCC)c2c1=O
c.) COc1ccc(CCC(C)Nc2cccc(F)c2)cc1
Answer: b. CCCCN(CC)C(=O)Cn1ncc2c3ccccc3n(CCC)c2c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCN(CC)C(=O)Cn1ncc2c3ccccc3n(CCC)c2c1=O
CCCCN(CC)C(=O)Cn1ncc2c3ccccc3n(CCC)c2c1=O
N-butyl-N-ethyl-2-(4-oxo-5-propylpyridazino[4,5-b]indol-3-yl)acetamide